Efficacy and Safety of Empagliflozin in Type 1 Diabetes Mellitus Patients: A Systematic Review
(Endocrinol Res Pract 2021; 25: 426-438) DOI: 10.25179/tjem.2021-83912
(Endocrinol Res Pract 2021; 25: 426-438) DOI: 10.25179/tjem.2021-83912
Emre Vuraloglu, Merve Alyamac Yasar, Esra Borazan, Altug Kut, Ayse Yavuz Derman, Özlem Turhan İyidir
(Endocrinol Res Pract 2025; 29: 22-29) DOI: 10.5152/erp.2025.24509